Archive for 2023

In this interview with PharmaBoardroom, Daniel Vella Friggieri, Regional CEO EME, outlines the rationale behind the merger of Europe & MENAT regions

Over the last few months, the Aspen Group Executives completed an in-depth review of the international commercial portfolio to ensure focus and alignment with Aspen’s business strategy geared towards delivering its stated objectives. This led to a strategic decision to merge the current Europe and MENAT regions into one growth region to achieve the objectives…

Dubai, United Arab Emirates – Aspen Healthcare FZ LLC (“Aspen Healthcare”), a subsidiary of Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded multinational pharmaceutical company, has entered into a memorandum of understanding (“MOU”) with Saudi Chemical Company Holding (“SCCH”), a well-known company in the local market of the Kingdom of Saudi Arabia, and…

Aspen, a leading global specialty and branded multinational pharmaceutical company, has positively responded to humanitarian calls for relief following the devastating 7.8 magnitude earthquake, along with a series of strong tremors and aftershocks, that tore through southeast Turkey and northwest Syria on 6 February 2023.